Literature DB >> 7505216

Expression of cell adhesion molecules in corneal graft failure.

S M Whitcup1, R B Nussenblatt, F W Price, C C Chan.   

Abstract

Corneal graft failure is frequently mediated by uncontrolled inflammatory disease. We studied the expression of cell adhesion molecules in seven penetrating keratoplasty specimens with graft failure and in a normal eye bank cornea using immunohistochemical staining and monoclonal antibodies against intercellular adhesion molecule-1 (ICAM-1, CD54), lymphocyte function-associated antigen-1 (LFA-1, CD11a/CD18), vascular cell adhesion molecule-1 (VCAM-1), E-selectin, and major histocompatibility complex (MHC) class II antigen (HLA-DR). ICAM-1 and HLA-DR were expressed on keratocytes and the corneal endothelium in six of the seven specimens. ICAM-1 expression was strongest in the corneas with the most severe inflammation (corneal allograft rejection and severe intraocular inflammation). LFA-1 is a counter-receptor for ICAM-1, and infiltration with leukocytes expressing either the alpha or beta chain of LFA-1 was found in areas of ICAM-1 expression in four of the seven corneas. In contrast, E-selectin was expressed in the stroma in only two specimens, and VCAM-1 in one specimen. Expression of cell adhesion molecules or MHC class II antigen were not detected in the normal eye bank cornea. These data suggest that ICAM-1 expression may play an important role in the development of corneal graft failure. Furthermore, monoclonal antibodies to block ICAM-1 or its ligands may inhibit the development of corneal inflammation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7505216     DOI: 10.1097/00003226-199311000-00003

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  9 in total

Review 1.  Concise review: immunological properties of ocular surface and importance of limbal stem cells for transplantation.

Authors:  Bakiah Shaharuddin; Sajjad Ahmad; Annette Meeson; Simi Ali
Journal:  Stem Cells Transl Med       Date:  2013-07-01       Impact factor: 6.940

2.  Update on the Management of High-Risk Penetrating Keratoplasty.

Authors:  Sayena Jabbehdari; Alireza Baradaran Rafii; Ghasem Yazdanpanah; Pedram Hamrah; Edward J Holland; Ali R Djalilian
Journal:  Curr Ophthalmol Rep       Date:  2017-02-02

3.  Paradigm shifts in the role of CD4+ T cells in keratoplasty.

Authors:  Khrishen Cunnusamy; Peter W Chen; Jerry Y Niederkorn
Journal:  Discov Med       Date:  2010-11       Impact factor: 2.970

Review 4.  Corneal allograft rejection.

Authors:  D F Larkin
Journal:  Br J Ophthalmol       Date:  1994-08       Impact factor: 4.638

5.  Function of the tryptophan metabolite, L-kynurenine, in human corneal endothelial cells.

Authors:  Nermin Serbecic; Imad Lahdou; Alexander Scheuerle; Romana Höftberger; Fahmy Aboul-Enein
Journal:  Mol Vis       Date:  2009-07-08       Impact factor: 2.367

6.  Comparison of topical interleukin-1 vs tumor necrosis factor-alpha blockade with corticosteroid therapy on murine corneal inflammation, neovascularization, and transplant survival (an American Ophthalmological Society thesis).

Authors:  Reza Dana
Journal:  Trans Am Ophthalmol Soc       Date:  2007

7.  Adhesion molecule expression in local-macrophage-depleted rats bearing orthotopic corneal allografts.

Authors:  Tanja P A M Slegers; Gerard van der Veen; L Joep A Hermans; Lidy Broersma; Nico van Rooijen; Hendrika J Völker-Dieben; Gabriel van Rij; Ruth van der Gaag
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-04-16       Impact factor: 3.117

Review 8.  Effector and Regulatory T Cell Trafficking in Corneal Allograft Rejection.

Authors:  Afsaneh Amouzegar; Sunil K Chauhan
Journal:  Mediators Inflamm       Date:  2017-04-28       Impact factor: 4.711

9.  Identification of differentially expressed genes in gauze-exposed omentum of dogs using differential display RT-PCR.

Authors:  Md Mizanur Rahman; Yongsun Kim; Ye-Eun Byeon; Hak-Hyun Ryu; Wan Hee Kim; Mahmuda Umme Rayhan; Oh-Kyeong Kweon
Journal:  J Vet Sci       Date:  2013-02-05       Impact factor: 1.672

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.